-
Product Insights
Better Living Health – Better Living at Thompson House Long-Term Care Home – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Better Living Health - Better Living at Thompson House Long-Term Care Home - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Better Engy/ Statkraft – Better Energy Resko Solar PV Park 36 MW – West Pomeranian Voivodeship
Equip yourself with the essential tools needed to make informed and profitable decisions with our Better Engy/ Statkraft - Better Energy Resko Solar PV Park 36 MW - West Pomeranian Voivodeship report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Product Insights
Better Life Grp – Pingjiang Urban Commercial Complex – Hunan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Better Life Grp - Pingjiang Urban Commercial Complex - Hunan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
A Better Choice for Property – Beaver Road Residential Community – Kent
Equip yourself with the essential tools needed to make informed and profitable decisions with our A Better Choice for Property - Beaver Road Residential Community - Kent report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Better Hsg Coalition – Winchester Forest Apartment Complex – Virginia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Better Hsg Coalition - Winchester Forest Apartment Complex - Virginia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Better Engy – Holstebro Solar PV Park 200MW – Central Jutland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Better Engy - Holstebro Solar PV Park 200MW - Central Jutland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Southend on Sea/ Swan Hsg Assn – Better Queensway Residential Community – Essex
Equip yourself with the essential tools needed to make informed and profitable decisions with our Southend on Sea/ Swan Hsg Assn - Better Queensway Residential Community - Essex report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Better Engy – Vierumaki Solar Power Plant 58 MW – Paijanne Tavastia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Better Engy - Vierumaki Solar Power Plant 58 MW - Paijanne Tavastia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Adventure Myanmar Tours/ BuBuGao Better Life – Magical World Mixed-Use Development – Yangon
Equip yourself with the essential tools needed to make informed and profitable decisions with our Adventure Myanmar Tours/ BuBuGao Better Life - Magical World Mixed-Use Development - Yangon report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Thematic Analysis
New![]()
Patient Consumerism – Thematic Intelligence
Patient consumerism is gaining momentum Within patient consumerism, patients are seen as well-informed ‘customers’ of healthcare who proactively use trustworthy, relevant information and appropriate technology to make better-informed medical decisions about their healthcare options. Healthcare is evolving from a ‘doctor knows best’ mentality to a patient-doctor relationship where the patient takes an active role in making informed healthcare decisions.
-
Thematic Analysis
New![]()
5G in Medical Devices – Thematic Intelligence
5G and the medical device industry As a result of the COVID-19 pandemic, 5G has been predominantly used in the medical devices industry in the field of telehealth. 5G-enabled sensors can be used for teleconferencing, allowing physicians to effectively monitor a patient’s vital signs and provide accurate and effective treatments during calls. The low latency of 5G also allows real-time remote patient monitoring with the streaming and analysis of patient data from an array of medical devices. 5G-enabled remote surgery...
-
Product Insights
NewUnited Kingdom (UK) Protection Insurance – Income Protection Market
The income protection (IP) market experienced strong growth in 2022, with high demand for the product amid the difficult economic climate, including the cost-of-living crisis. The independent advice channel dominates, with consumers continuing to seek out advice to better understand their coverage needs as well as find the best value option. Insurers have continued adapting and adjusting products during these changing times. Innovations have revolved around consolidating multiple IP products into a single, easy-to-understand product and partnering with protection panels...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Myelodysplastic Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PRGN-3006 in Myelodysplastic Syndrome Drug Details: PRGN-3006 is under development for the treatment of cancer including...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Refractory Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PRGN-3006 in Refractory Acute Myeloid Leukemia Drug Details: PRGN-3006 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Relapsed Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PRGN-3006 in Relapsed Acute Myeloid Leukemia Drug Details: PRGN-3006 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRGN-3006 in Chronic Myelomonocytic Leukemia (CMML)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PRGN-3006 in Chronic Myelomonocytic Leukemia (CMML) Drug Details: PRGN-3006 is under development for the treatment of...
-
Track & Monitor
NewClinical Trials Feasibility Risk Assessment and Planning for Success – A Depression Case Study
This report provides the global clinical trial landscape for depression and identifies key analysis of the main features in order to run similar trials successfully. As the prevalence of depression has increased, the outlook of it has also changed in positive ways. Better support and services for depression as well as the increase of discussing this order has lead to an increase of depression clinical trials. The COVID-19 pandemic has played a major role in that.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etanercept Biobetter in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Etanercept Biobetter in Rheumatoid ArthritisDrug Details:Etanercept bio-better is under development for the treatment of rheumatoid arthritis....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Insulin Lispro U100 in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Insulin lispro is under development for...
-
Sector Analysis
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032
The prevalence of vWD is increasing at a steady rate, in line with population growth in the 3MM, at an AGR of 0.61%. Currently, the treatment regimen for vWD in the 3MM is mostly limited to DDAVP and coagulation factor VIII + vWF complex. There are several unmet needs in this space, including the need for better diagnostic tools for vWD and improved therapies for severe vWD. The vWD late-stage R&D pipeline is focused on developing vWF recombinant for pediatric...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.